Board of Directors
Anthony Hickey, Ph.D.
Walter Flicker, M.BioMedEng. Mr. Flicker has over 30 years experience in the life sciences industry, and brings a wealth of experience in the pre-public and public company financial areas. He provides consulting services to start-up companies and venture funds. A major project involved supporting a Los Angeles start-up with the development, clinical trials and FDA clearance of a novel respiratory treatment device, resulting in the sale of the company to Viasys Healthcare (now part of Cardinal Health) for over $20 million.
Previously, Mr. Flicker was the CFO of Respiratory Technology Corporation (Restech). Restech�s novel sensor for non-invasively detecting gastric reflux in the upper airway is gaining increased acceptance in the ENT/pulmonary medicine area, particularly in pediatrics.
Mr. Flicker was a founding executive and officer of ResMed Inc (NYSE: RMD). Mr. Flicker was the initial CFO of ResMed (1989 � 1995) and was responsible for helping take the company from its founding to its public listing on Nasdaq. As CFO Mr. Flicker was responsible for capital raising, financial reporting and financial control and treasury functions. After the Company�s Nasdaq listing, Mr. Flicker held positions as Vice President Corporate Development, Vice President, US Operations and Vice President, Assistant to the Chairman of ResMed. Mr. Flicker holds Bachelor of Engineering (First Class Honors) and Master of Biomedical Engineering degrees from the University of New South Wales, Australia. Mr. Flicker�s strengths are in developing, analyzing and initiating new medical business opportunities for global markets; budgeting and strategic planning; and the management of start-up companies within tight business and financial constraints.
Copyright KAER Biotherapeutics Corporation. All Rights Reserved